Searchable abstracts of presentations at key conferences in endocrinology

ea0090rc10.1 | Rapid Communications 10: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2023

Gold and cerium oxide nanoparticles reduce liver steatosis and inflammation in rats with steatohepatitis

Casals Gregori , Lecue Elena , Shahbazi Shayan , Guo Dongdong , Perramon Meritxell , Zeng Muling , Jimenez Wladimiro , Morales-Ruiz Manuel , Casals Eudald , Fernandez-Varo Guillermo

Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by the presence of hepatic steatosis, which can progress to non-alcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma. There are no licensed therapies to halt MAFLD progression, despite it is becoming the most important etiology for advanced liver disease.Aim: The aim of the study was to evaluate the therapeutic potential of inorganic nanopartic...